Literature DB >> 23146369

Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.

N Duport1.   

Abstract

BACKGROUND: This study aimed at (i) estimating the 2-year self-reported breast cancer screening coverage rate; and (ii) analyzing the relationships between sociodemographic characteristics and healthcare access of women and breast cancer screening (opportunistic or organized) practices.
METHODS: From a 2006 French health survey, 2056 women aged 50 to 74 years were selected and divided into three groups according to their breast cancer screening practices during the previous 2 years: organized screening, opportunistic screening, or no screening. The three groups were compared according to self-reported sociodemographic status, healthcare access, screening behaviors, and perceived health, using polytomic regression.
RESULTS: The 2-year self-reported coverage rate was 75.8%. It was high among women aged 50 to 69 years and lower among older women. Questions relating to medical access (i.e. having consulted a GP in the last 12 months, having consulted a gynecologist in the last 12 months, and having had a Pap smear in the last 3 years) were the variables most commonly associated with a recent mammogram. Women having a regular follow-up by a gynecologist or having had cervical cancer screening within the last three years used organized breast cancer screening more often and used opportunistic breast cancer screening even more often than other women.
CONCLUSION: The study confirmed the key role of gynecologists and general practitioners in encouraging women to have a mammogram. Awareness among healthcare professionals and women of the benefits of organized breast cancer screening compared to opportunistic screening should be sustained and strengthened.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146369     DOI: 10.1016/j.respe.2012.05.006

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  7 in total

1.  Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data.

Authors:  Jonathan Sicsic; Carine Franc
Journal:  Eur J Health Econ       Date:  2016-06-21

2.  Does lack of resources impair access to breast and cervical cancer screening in Japan?

Authors:  Hiroshi Sano; Rei Goto; Chisato Hamashima
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

3.  Determinants of Non-Participation in Population-Based Breast Cancer Screening: A Systematic Review and Meta-Analysis.

Authors:  Lilu Ding; J Wang; M J W Greuter; M Goossens; Guido Van Hal; Geertruida H de Bock
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

4.  Are immigrants and nationals born to immigrants at higher risk for delayed or no lifetime breast and cervical cancer screening? The results from a population-based survey in Paris metropolitan area in 2010.

Authors:  Claire Rondet; Annabelle Lapostolle; Marion Soler; Francesca Grillo; Isabelle Parizot; Pierre Chauvin
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

5.  Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.

Authors:  Panayotis Constantinou; Rosemary Dray-Spira; Gwenn Menvielle
Journal:  BMC Cancer       Date:  2016-03-31       Impact factor: 4.430

6.  Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening.

Authors:  Monika Eichholzer; Aline Richard; Sabine Rohrmann; Seraina M Schmid; Cornelia Leo; Dorothy J Huang; Uwe Güth
Journal:  BMC Health Serv Res       Date:  2016-09-23       Impact factor: 2.655

7.  Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade.

Authors:  L Ding; S Jidkova; M J W Greuter; K Van Herck; M Goossens; P Martens; G H de Bock; G Van Hal
Journal:  Int J Equity Health       Date:  2020-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.